Paolo Prandoni
Di Paolo Prandoni | 3 Dicembre 2014 | 0
Ultima modifica: 22 Dicembre 2023
Nato il 7-9-1947. Laureato l’11-12-1971. Specialista in Ematologia (1974), Medicina Interna (1976)...
CLOT+ RSS Feed- Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093/eurheartj/ehae596.
- Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093/eurheartj/ehae617.
- Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study.J Thromb Haemost. 2024 Aug 10:S1538-7836(24)00444-6. doi: 10.1016/j.jtha.2024.07.024.